◆
BLACKSPECTER
AI Chat öffnen →
BlackSpecter
›
Aktien
›
LLY
LLY
(LLY)
Kennzahlen
Marktkapitalisierung
n/a
KGV (TTM)
n/a
Umsatz (TTM)
n/a
EBITDA
n/a
Dividendenrendite
n/a
52W Hoch
n/a
52W Tief
n/a
Beta
n/a
EPS (TTM)
n/a
Forward KGV
n/a
PEG Ratio
n/a
Short-Quote
n/a
Analysten-Ratings
Keine Analysten-Daten verfügbar
Earnings
Keine Earnings-Daten verfügbar
Aktuelle News
GlobeNewswire
·
vor 27 Min.
VivoSim Receives $5M Milestone Payment from Eli Lilly; Provides Guidance That It Expects Revenue Growth of 500%+ in FY2027
MT Newswires
·
vor 1 Std.
Market Chatter: Eli Lilly-Backed AdvanCell Raises $315 Million From New Funding Round
MT Newswires
·
vor 1 Std.
Citigroup Adjusts Price Target on Eli Lilly to $1,600 From $1,500, Maintains Buy Rating
Bloomberg
·
vor 2 Std.
Eli Lilly-Backed Novel Cancer Therapy Firm Raises $315 Million
Simply Wall St.
·
vor 7 Std.
Eli Lilly (LLY) Wins Full FDA Approval For Retevmo In Broader Cancers
The Wall Street Journal
·
vor 12 Std.
In the Weight-Loss Wars, Novo’s Obesity Pill Is Pulling Way Ahead of Lilly’s
Frag BlackSpecter AI über LLY
Earnings-Analyse, Bewertungs-Check, Peer-Vergleich — in Sekunden.
Ist LLY kaufenswert?
LLY Earnings Analyse
LLY Bewertung
AI Chat öffnen →